Published in Cancer Weekly, May 4th, 1998
The patent, based on discoveries from Case Western Reserve University and assigned to Osiris, covers the use of MSCs in bone marrow and hematopoietic stem cell transplants to reconstitute bone marrow stroma, the connective tissue in bone marrow upon which blood cell formation occurs.
Osiris has been engaged in the research and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.